GENEVA, Sept. 3 -- ABDERA THERAPEUTICS INC. (901 Gateway Blvd.South San Francisco, California 94080) filed a patent application (PCT/US2025/016646) for "DLL3 BINDING IMMUNOCONJUGATES AND USES THEREOF" on Feb 20, 2025. With publication no. WO/2025/179051, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ABRAMS, Michael J. (901 Gateway Blvd.South San Francisco, California 94080), CUMMINS, Emma Jane (1700 West 7th AvenueVancouver, British Columbia V6J 4Z9), JUDGE, Adam Daniel (901 Gateway Blvd.South San Francisco, California ...